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OBJECTIVE—It is well established that the primary mediators
of -cell destruction in type 1 diabetes are T-cells. Nevertheless,
the molecular basis for recognition of -cell–speciﬁc epitopes by
pathogenic T-cells remains ill deﬁned; we seek to further explore
this issue.
RESEARCH DESIGN AND METHODS—To determine the
properties of -cell–speciﬁc T-cell receptors (TCRs), we charac-
terized the ﬁne speciﬁcity, functional and relative binding avidity/
afﬁnity, and diabetogenicity of a panel of GAD65-speciﬁc CD4

T-cell clones established from unimmunized 4- and 14-week-old
NOD female mice.
RESULTS—The majority of GAD65-speciﬁc CD4
 T-cells iso-
lated from 4- and 14-week-old NOD female mice were speciﬁc for
peptides spanning amino acids 217–236 (p217) and 290–309
(p290). Surprisingly, 31% of the T-cell clones prepared from
14-week-old but not younger NOD mice were stimulated with
both p217 and p290. These promiscuous T-cell clones recognized
the two epitopes when naturally processed and presented, and
this dual speciﬁcity was mediated by a single TCR. Furthermore,
promiscuous T-cell clones demonstrated increased functional
avidity and relative TCR binding afﬁnity, which correlated with
enhanced islet inﬁltration on adoptive transfer compared with
that of monospeciﬁc T-cell clones.
CONCLUSIONS—These results indicate that promiscuous rec-
ognition contributes to the development of GAD65-speciﬁc CD4

T-cell clones in NOD mice. Furthermore, these ﬁndings suggest
that T-cell promiscuity reﬂects a novel form of T-cell avidity
maturation. Diabetes 57:2099–2106, 2008
T
ype 1 diabetes is characterized by the autoim-
mune-mediated destruction of the insulin-pro-
ducing -cells of the islets of Langerhans (1–3).
Based on studies in the nonobese diabetic
(NOD) mouse, a spontaneous model of type 1 diabetes, the
primary effectors of -cell destruction are CD4
 and CD8

T-cells (1,4–6). Early during -cell autoimmunity, a select
panel of autoantigens, including proinsulin, insulin,
GAD65, islet-speciﬁc glucose-6-phosphatase catalytic sub-
unit–related protein (IGRP), and dystrophia myotonica
kinase, are targeted by CD4
 and CD8
 T-cells in NOD
mice (7–12). As the diabetogenic response proceeds,
-cell–speciﬁc T-cell reactivity “spreads” in a relatively
deﬁned pattern (13,14). Additional autoantigenic determi-
nants are sequentially recognized within a single protein
(intramolecularly) and among different antigens (intermo-
lecularly) to effectively amplify the diabetogenic response.
The key events involved in the breakdown of self-
tolerance within the T-cell compartment and which shape
the T-cell receptor (TCR) repertoire of -cell–speciﬁc
T-cells remain ill deﬁned. Studies have suggested that
defective thymic negative selection contributes to in-
creased production of -cell–speciﬁc T precursors (15–
17). Furthermore, the peptide-binding properties of major
histocompatibility complex (MHC) class II and class I
molecules that are associated with type 1 diabetes suscep-
tibility are thought to shape the TCR repertoire of diabe-
togenic T-cell effectors (18–22). Properties intrinsic to
-cell–speciﬁc TCRs may also contribute to the pathoge-
nicity of T-cell effectors. For instance, avidity maturation
promotes the expansion of IGRP-speciﬁc CD8
 T-cells
that in turn display increased TCR avidity/afﬁnity and
enhanced pathogenicity (23). One intriguing possibility is
that the pathogenicity of an autoreactive T-cell is inﬂu-
enced by the degree of TCR cross-reactivity. In this model,
a T-cell expressing a TCR that cross-reacts with multiple
-cell–derived epitopes would be selectively expanded
and exhibit increased pathogenicity.
Antigen recognition by TCRs is inherently degenerate
(24–26). Furthermore, a number of studies have reported
cross-reactive T-cell responses between synthetic peptides
that exhibit little if any sequence homology with the
natural ligand (27–30). Allogeneic recognition by T-cells
provides a biologically relevant example of the ﬂexibility
associated with TCR recognition (31,32). Goverman and
colleagues (33) demonstrated the presence of CD4
 T-
cells recognizing two nonoverlapping epitopes of myelin
basic protein (MBP) in a murine model of experimental
autoimmune encephalomyelitis (EAE). This ﬁnding sug-
gests that cross-reactive or “promiscuous” T-cell clono-
types may promote tissue-speciﬁc autoimmunity. Other
studies have reported promiscuous recognition of non-
overlapping epitopes within the same viral or foreign
antigen by CD4
 and CD8
 T-cells (34–36). The molecular
basis and functional impact of T-cell promiscuity remains
largely undeﬁned.
In an effort to determine the properties of -cell–speciﬁc
TCRs, we prepared a large panel of GAD65-speciﬁc CD4

T-cell clones isolated from unimmunized 4- and 14-week-
old NOD female mice. We demonstrate that a signiﬁcant
frequency of these T-cell clones recognize nonoverlapping
peptides derived from GAD65, and that this promiscuity
correlates with increased pathogenicity.
RESEARCH DESIGN AND METHODS
NOD/LtJ and NOD.CB17.Prkdc
scid/J (NOD.scid) mice were maintained and
bred under speciﬁc-pathogen–free conditions, in a facility accredited by the
American Association of Laboratory Animal Care. All procedures were
approved by the University of North Carolina Institutional Animal Care and
Use Committee.
Establishment of GAD65-speciﬁc CD4
 T-cell clones. GAD65-speciﬁc
T-cell clones were established from unimmunized 4- and 14-week-old NOD
female mice with full-length murine GAD65 and cloned by limiting dilution as
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DIABETES, VOL. 57, AUGUST 2008 2099described previously (37). Subclones were expanded and monoclonality was
conﬁrmed via staining with available anti–variable (V) and -V–speciﬁc
antibodies (Abs) and/or inverse RT-PCR (see below). T-cell clones were
maintained on a 21-day growth cycle in which 2  10
6 T-cells were stimulated
with 2  10
7 irradiated (3,000 rad) splenocytes and 10 g/ml GAD65. On day
3, base medium containing 10% FBS and 20 units/ml interleukin (IL)-2 was
added, and cultures were expanded accordingly up to 21 days.
Expression and puriﬁcation of soluble IA
g7-Ig fusion proteins. Soluble
(s) IA
g7-Ig dimers were engineered as previously described (38). Brieﬂy, IA
g7
- and -chain extracellular domains were attached to fos and jun leucine
zippers, respectively. Peptide epitopes were covalently linked to the NH2
terminus of the IA
g7-chain by a ﬂexible thrombin-GGGGS linker. cDNAs
encoding the respective sIA
g7-Ig chains were subcloned into the pMT-Bip
vector (Invitrogen, Carlsbad, CA) and transgene expression driven by a
metallothionein-inducible promoter. Expression vectors were cotransfected
via calcium phosphate into Drosophila S2 cells with pHygro, and stable
transfectants were selected in hygromycin-containing Schneider’s medium.
sIA
g7-Ig dimer protein expression was induced by 500 mol/l CuSO4 for 7–10
days and puriﬁed by afﬁnity chromatography on a Protein A column (GEBio-
science, Pittsburgh, PA).
Flow cytometry. sIA
g7-Ig dimers were multimerized using biotin- or Alexa
647–coupled Protein A (Molecular Probes, Invitrogen, Eugene, OR) for ﬂow
cytometric analyses (38). Cells were incubated with sIA
g7-Ig multimers at 37°C
for 1 h, followed by streptavidin-phycoerythrin, anti-CD3 (ﬂuorescein isothio-
cyanate), and CD4 (peridinin-chlorophyll-protein complex) antibodies stain-
ing on ice for 30 min (eBioscience, San Diego, CA). Data were acquired on a
Cyan ﬂow cytometer (DakoCytomation, Carpinteria, CA) and analyzed using
Summit software (DakoCytomation).
T-cell proliferation and cytokine assays. Proliferation assays were per-
formed as previously described (37). Brieﬂy, 2  10
4 T-cells were cultured in
triplicate with 2  10
5 irradiated (3,000 rad) splenocytes per well (0.2 ml) plus
antigen in a 96-well round-bottom microtiter plate for 72 h. Proliferation was
measured by uptake of [
3H]thymidine (1 Ci/well) during the last 16 h of
culture using a Trilux 1450 Microbeta Wallac Harvester (Wallac, Turku,
Finland).
A capture enzyme-linked immunosorbent assay (ELISA) using paired
antibodies purchased from BD Pharmigen was used to measure cytokine
secretion from supernatants harvested after 48 h of culture. The concentration
of interferon- (IFN-), IL-2, and IL-4 was determined in triplicate in 0.1 ml
culture supernatant by comparing with a standard curve of the respective
cytokines. The lower limits of detection for IFN-, IL-2, and IL-4 were 50, 25,
and 30 pg/ml, respectively.
Antigens. Full-length murine GAD65 containing a histidine tag on the COOH
terminus was expressed via Baculovirus and puriﬁed as previously described
(37). Histidine-tagged fragments encoding murine GAD65 spanning amino
acids 112–282 (f217), 240–439 (f290), and 160–364 (f217f290) or chloroform
acetyltransferase (fCAT) were expressed in Escherichia coli using the TrcHis
expression system (Invitrogen) and puriﬁed under denaturing conditions via
Ni
2 afﬁnity chromatography and preparative SDS-PAGE. Peptides were
synthesized using standard F-moc chemistry on a Rainin Symphony (Rainin
Instruments) at the peptide synthesis facility of University of North Carolina.
The purity of the peptides was veriﬁed by reverse-phase high-performance
liquid chromatography and mass spectroscopy.
Inverse PCR. Total RNA was extracted from 1  10
6 T-cells via Trizol
(Invitrogen) and reverse transcribed using oligo-dT primers. Second-strand
DNA was synthesized with 1 unit RNase H, 5 units E. coli ligase, and 25 units
E. coli DNA polymerase I for 16 h at 14°C. Double-stranded DNA (dsDNA) was
treated with T4 DNA polymerase to blunt both 5 and 3 ends and facilitate
intramolecular ligation by T4 DNA ligase. Primers encoding the constant
region of the TCR - and -chains were used to amplify circularized TCR
dsDNA. PCR amplicons were cloned into pCR2.1 Topo vector (Invitrogen) and
sequenced by the University of North Carolina Genomics Core Facility.
Construction, expression, and puriﬁcation of single-chain TCR. Single-
chain TCR (scTCR) was constructed as previously described (39). Brieﬂy, cDNA
encoding the 11H11 clonotypic TCR was ampliﬁed by RT-PCR. The TCR V- and
V-chain gene segments were engineered with a 4GGGGS ﬂexible linker via
overlapping PCR and a human Ig constant  domain and 12-histidine tag added
to the COOH terminus. The scTCR was subcloned into the expression vector
pAK400, and the plasmid was transformed into BL21 E. coli (Stratagene, La Jolla,
CA). Expression of scTCR was induced with 1 mmol/l IPTG for 16 h, after which
the periplasm was extracted via osmotic shock. scTCR was then puriﬁed under
native conditions by Co
2 afﬁnity chromatography.
Surface plasmon resonance. A Biacore 2000 instrument (Biacore, Piscat-
away, NJ) was used to measure binding interactions between puriﬁed sIA
g7-Ig
dimers and scTCRs. sIA
g7-Ig dimer was immobilized by amine-coupling
chemistry on a CM5 research-grade sensor chip. Surface densities for individ-
ual experiments are indicated in Fig. 4. scTCRs were prepared in ﬁltered and
degassed PBS and injected at a ﬂow rate of 20 l/min. In all experiments, one
blank channel was used as a negative control. KD values as well as on and off
rates were obtained by nonlinear curve ﬁtting of subtracted curves using the
Langmuir 1:1 binding model with the BIAevaluation program (version 3.0.2;
Biacore) and the global-ﬁtting software Clamp (version 3.3). The equilibrium
KD, under steady-state conditions, was also determined using the BIA evalu-
ation program.
Measurement of relative TCR binding afﬁnity. The association kinetics
measured using the multimers were determined using a previously described
method (40). Brieﬂy, T-cell clones were stained with anti-TCR antibody and
increasing concentrations of sIA
g7-Ig multimers for1ha troom temperature.
Data were normalized to the level of TCR expression. The apparent KD values
were derived from the negative reciprocal of the slope of the regression line
ﬁt to Scatchard plots of bound multimer/free multimer (normalized ﬂuores-
cence units per nanomolar concentration of multimer) versus bound multimer
(normalized ﬂuorescence units).
T-cell adoptive transfers and histopathology. “Resting” T-cell clones
(10  10
6) stimulated with peptide 21 days prior were injected intraperitone-
ally into 5- to 8-week-old NOD.scid male mice. Recipient mice were monitored
for diabetes incidence. Pancreases were harvested and ﬁxed with 10%
formalin. Serial cross-sections (5 m) were cut and stained with hematoxylin-
eosin (H-E).
Islet isolation. Pancreases were perfused with 2 mg/ml collagenase P and
incubated for 30 min at 37°C, and the homogenate was applied to a Ficoll
gradient. Islets were washed, handpicked, and then dissociated by treatment
with 0.5 mg/ml collagenase D for 30 min at 37°C.
Statistical methods. Student’s t test and 	
2 analyses were carried out to
determine statistical signiﬁcance.
RESULTS
GAD65-speciﬁc CD4
 T-cells recognize two nonover-
lapping epitopes. To investigate the properties intrinsic
to -cell–speciﬁc TCRs and autoantigen recognition, we
used GAD65-speciﬁc CD4
 T-cell clones established from
the spleens of unimmunized 4- or 14-week-old NOD female
mice. -Cell autoimmunity and GAD65-speciﬁc CD4
 T-
cell reactivity are initially detected in NOD female mice at
3–4 weeks of age. In contrast, -cell autoimmunity is well
established in 14-week-old NOD female mice. Eighty-nine
CD4
 T-cell clones were established from 4-week-old NOD
female mice using intact murine GAD65 for T-cell stimu-
lation. Using a panel of overlapping GAD65-derived 20-mer
peptides, 88 clones were speciﬁc for a peptide spanning
amino acid residues 217–236 (p217) (Table 1; Fig. 1A).
These clones exhibited Th0-like (IL-2
) or Th1-like (IL-2
,
IFN-
) phenotypes based on ELISA (for cytokine secre-
tion by a subset of these clones, see Supplementary Table
1, which is detailed in the online appendix [available at
http://www.dx.doi.org/10.2337/db08-0383]). A minimum of
25 distinct clonotypes was identiﬁed based on ﬂow cyto-
metric analysis with available TCR V- and V-speciﬁc
antibodies and oligonucleotide sequencing of RT-PCR
ampliﬁed V and V gene segments. A single clone (6H1)
speciﬁc for GAD65 290–309 (p290) (Table 1; Fig. 1A) was
identiﬁed, which exhibited a Th2-like phenotype (IL-2
,
IL-4
) (see Supplementary Table 1) (37).
A total of 150 GAD65-speciﬁc CD4
 T-cell clones were
established from 14-week-old NOD female mice. Several
different GAD65-derived peptides, including p217 and
p290, were recognized by these CD4
 T-cell clones (Table
1). The majority (
90%) of these T-cell clones exhibited a
Th1-like phenotype (IL-2
, IFN-
), whereas the remain-
der of clones were Th0-like (IL-2
) (for cytokine secretion
by a subset of these clones, see Supplementary Table 1).
Surprisingly, 50 of the T-cell clones (33%) were stimulated
by two nonoverlapping GAD65-speciﬁc peptides (Table 1).
Most of these promiscuous T-cell clones responded to
p217 and p290 (47 of 150); 3 T-cell clones recognized both
peptides p290 and 400–420 (p400) (Table 1). Furthermore,
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phenotype (IL-2
, IFN-
) (for cytokine secretion by a
subset of these clones, see Supplementary Table 1).
To rule out the possibility that T-cell promiscuity was an
in vitro artifact of cloning, multimerized sIA
g7-Ig dimers
were used to detect promiscuous CD4
 T-cells in the
spleen, pancreatic lymph nodes (PLNs), mesenteric lymph
nodes (MLNs), and islets of nondiabetic 12-week-old NOD
female mice. The sIA
g7-Ig dimers contain covalently linked
p217, p290, or a hen egg lysozyme-derived peptide (pHEL)
as a control. As shown in Fig. 1B and C, CD3
CD4
 T-cells
binding both sIA
g7-p217 and sIA
g7-p290 multimers were
TABLE 1
GAD65 peptide speciﬁcity of CD4
 T-cell clones established from unimmunized NOD female mice
GAD65 peptide Amino acid sequences Clones
4-week-old NOD female mice*
p217–236 EYVTLKKMREIIGWPGGSGD 88 (98.9)
p290–309 AALGIGTDSVILIKCDERGK 1 (1.1)
Total 89
14-week-old NOD female mice*
p16–36 GSGDSENPGTARAWCQVAQKF 5 (3.3)
p202–221 TNMFTYEIAPVFVLLEYVTL 13 (8.7)
p217–236 EYVTLKKMREIIGWPGGSGD 36 (24)
p232–251 GGSGDGIFSPGGAISNMYAM 14 (9.3)
p290–309 AALGIGTDSVILIKCDERGK 22 (14.7)
p400–420 VPLQCSALLVREEGLMQNCNQ 6 (4.0)
p561–575 ISNPAATHQDIDFLI 4 (2.7)
p217–236  p290–309 47 (31.3)
p290–309  p400–420 3 (2.0)
Total 150
Data are n (%) of T-cell clones speciﬁc for single or dual GAD65-derived peptides. *GAD65-speciﬁc T-cell clones were established from two
independent cloning experiments in which spleens from three to ﬁve donor NOD female mice either 4 or 14 weeks of age were pooled in a
single experiment.
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FIG. 1. GAD65-speciﬁc CD4
 T-cells exhibit promiscuous recognition of p217 and p290. A: Clones representative of p217 (1A4) and p290 (6H1)
monospeciﬁc or promiscuous (11H11) T-cells were stimulated with p217, p290, GAD65 protein, or OVA peptide (321–339) as negative control,
and proliferation was measured via [
3H]thymidine uptake. B: Representative ﬂow cytometric data for CD4
 T-cells isolated from the islets of a
12-week-old NOD female mouse and co-stained with sIA
g7-p217 and sIA
g7-p290 multimers or sIA
g7-pHEL multimers as a control. C: The frequency
of promiscuous CD4
 T-cells detected ex vivo in the spleen, PLNs, MLNs, and islets of 12-week-old NOD female mice. The average percentages
of promiscuous CD4
 T-cells  SD calculated from ﬁve independent experiments are presented. *P < 0.004, PLNs vs. MLNs; **P < 0.003, islets
vs. MLNs; Student’s t test.
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spleen, but not the MLNs. Together these ﬁndings indicate
that GAD65-speciﬁc CD4
 T-cells recognizing nonoverlap-
ping epitopes are present in NOD female mice at a late
preclinical stage of type 1 diabetes.
Promiscuous GAD65-speciﬁc CD4
 T-cell clones rec-
ognize naturally processed and presented p217 and
p290 epitopes with increased avidity. Various studies
have shown that T-cells may respond to a synthetic
peptide but not to the corresponding naturally processed
epitope, thereby bringing into question the physiological
relevance of the former. To ensure that the promiscuous
CD4
 T-cell clones recognized naturally processed and
presented p217 and p290 epitopes, the stimulatory capac-
ity of recombinant fragments of GAD65 containing the
p217 (f217) or p290 (f290) epitopes only or both p217 and
p290 epitopes (f217  290) was tested. As expected,
monospeciﬁc p217 (1A4) and p290 (6H1) T-cell clones
responded to the corresponding GAD65-speciﬁc recombi-
nant proteins, but a fCAT recombinant used as a negative
control did not (Fig. 2). Signiﬁcant proliferation of the
promiscuous 11H11 clone was induced by both f217 and
f290 but not fCAT (Fig. 2). These results demonstrate that
promiscuous T-cell clones are readily stimulated by pro-
tein containing the p217 and p290 epitopes.
Interestingly, the promiscuous 11H11 clone exhibited a
more robust proliferative response to f217 and f290 rela-
tive to the monospeciﬁc 1A4 and 6H1 clones (Fig. 2). This
ﬁnding suggested that promiscuous TCR recognition en-
hanced T-cell responsiveness to antigen. To further inves-
tigate this possibility, proliferation of several monospeciﬁc
and promiscuous T-cell clones in response to the panel of
GAD65-speciﬁc recombinant proteins was measured in
greater detail. Speciﬁcally, the concentration of antigen
that elicited 50% of the maximum proliferative response
(e.g., [EC50]) was determined. The average [EC50]m e a -
sured in response to f217 and f290 for the monospeciﬁc
p217 and p290 T-cell clones was 452  173 and 668  163
nmol/l, respectively (Table 2). Strikingly, the average
[EC50] of the panel of promiscuous T-cell clones was
increased 4.9- and 2-fold for f217 (93  47 nmol/l) and
f290 (367  71 nmol/l), respectively, relative to the corre-
sponding panel of monospeciﬁc T-cell clones (Table 2).
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FIG. 2. Promiscuous CD4
 T-cell clones recognize naturally processed and presented p217 and p290 epitopes. Clones representative of p217
(1A4) and p290 (6H1) monospeciﬁc or promiscuous (11H11) T-cells were stimulated with GAD65 fragments containing p217 (f217), p290 (f290),
or both p217 and p290 (f217  290) or an irrelevant protein (fCAT), and proliferation was measured via [
3H]thymidine uptake. Data are
representative of a minimum of six independent experiments.
TABLE 2

EC50 determination for GAD65-speciﬁc T-cell clones
Speciﬁcity Clone* f217 (nmol/l) f290 (nmol/l) f217  290 (nmol/l)
p217–236 1A4 240  36 NR 200  21
2C11 564  76 NR 530  90
5B7 385  42 NR 310  38
1C9 620  99 NR 604  85
Average 452  173 NR 411  188
p290–309 6H1 NR 460  63 424  55
1A2 NR 854  105 807  122
5A7 NR 710  86 765  93
6C10 NR 650  79 680  102
Average NR 668  163 669  171
p217–236  p290–309 11H11 40  19 250  38 35  14
7E10 54  23 390  57 33  10
4D10 125  41 440  63 62  25
10C1 58  15 357  50 40  20
4B5 94  36 330  48 60  28
11C11 59  20 320  76 32  8
8A9 161  34 369  85 144  37
11A10 149  30 480  106 83  45
Average 93  47† 367  71† 61  38
Data are means  SE. The concentration of f217, f290, and f217  290 inducing 
EC50 measured by 

3Hthymidine uptake is provided for
the respective T-cell clones. *Clones 1A4 and 6H1 were established from 4-week-old NOD female mice; all other clones were established from
14-week-old NOD female mice. †P  10
3, the average 
EC50 of the group of promiscuous vs. p217–236– or p290–309–speciﬁc T-cell clones
(Student’s t test). NR, no response.
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speciﬁc T-cell clones have an increased [EC50].
To conﬁrm the above observation, sIA
g7-p217 and sIA
g7-
p290 binding by the respective T-cell clones was measured
and analyzed via Scatchard plot. Normalizing for the level
of TCR expression, the average relative TCR afﬁnity of the
promiscuous T-cell clones was increased ﬁvefold for sIA
g7-
p217 (KD  15.1  2.8 nmol/l) compared with p217-
speciﬁc T-cell clones (KD  76.7  16.9 nmol/l; P  0.005;
Student’s t test) (Fig. 3). No signiﬁcant difference in
relative TCR afﬁnity for p290 was detected between the
promiscuous (KD  72.9  17.6 nmol/l) and p290-only–
speciﬁc (KD  75.2  22.6 nmol/l) T-cell clones (Fig. 3).
Together, these results demonstrate that promiscuous
TCR recognition correlates with an increased [EC50] and
enhanced relative TCR afﬁnity speciﬁc for p217.
Promiscuous T-cell clones recognize dual epitopes
using a single TCR. Next, TCRs expressed by the clones
were analyzed to determine whether promiscuous peptide
recognition 1) was attributed to expression of a single
TCR versus dual/multiple TCRs and 2) correlated with
selective TCR V and/or V gene usage. An inverse PCR
strategy was used to amplify full-length V gene regions
from cDNA prepared from each T-cell clone. In this way, if
a given T-cell clone expressed multiple – and/or –TCR
chains, functional (and aberrant) mRNA transcripts would
be readily cloned independent of the V gene family. All
monospeciﬁc and promiscuous T-cell clones expressed a
single TCR (Table 3). Furthermore, there was no signiﬁ-
cant sharing of V or V gene usage or V and V
complementary determining region (CDR3) motifs among
the promiscuous (or monospeciﬁc) T-cell clones (Table 3).
To unambiguously demonstrate that a single TCR bound
both p217 and p290, a soluble scTCR from the promiscu-
ous 11H11 clone was engineered, and binding kinetics to
sIA
g7-p217 and sIA
g7-p290 were measured via surface
plasmon resonance. Both sIA
g7-p217 and sIA
g7-p290 bound
to 11H11 scTCR with KD values of 38.8  3.9 and 117.6 
15.2 mol/l, respectively (Fig. 4). These results demon-
strate that promiscuous T-cell clones express a single TCR
and that TCR gene usage is heterogeneous.
Promiscuous T-cell clones exhibit an enhanced ca-
pacity to mediate insulitis. Because the promiscuous
T-cell clones demonstrated enhanced [EC50] and sIA
g7-Ig
binding avidity, we hypothesized that promiscuous versus
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FIG. 3. Promiscuous CD4
 T-cell clones exhibit an increased relative
TCR avidity/afﬁnity. sIA
g7-p217 (A) and sIA
g7-p290 (B) multimer bind-
ing by monospeciﬁc p217 (1A4 and 5B7) and p290 (6H1 and 1A2) and
promiscuous (4B5, 7E10, 11C11, and 11H11) T-cell clones was mea-
sured by Scatchard plot analysis. The binding data were ﬁtted to a
standard Scatchard plot, and KD was calculated by the slope of the line.
Data are the average of two independent experiments.
TABLE 3
TCR repertoire of the monospeciﬁc and promiscuous CD4
 T-cell clones
Speciﬁcity Clone V -J  CDR3V -D-J CDR3
6H1 V2-J44 YFCAA SNTGANTGKL TFG V14-D1-J2.5 YLCAW SQLGANQDTQ YFG
1A2 V4-J39 YFCAL VDYANKM IFG V11-D1-J1.3 YLCAS SRTGSSYEQ YFG
p290 5A7 V4-J39 YFCAL VDYANKM IFG V8.2-D2-J2.5 YFCAS GDAGGAQDTQ YFG
6C10 V3-J26 YFCAG GSNYQL IWG V8.2-D1-J2.6 YFCAS GDRLGVYEQ YFG
p217 2C11 V17-J26 YFCAM REDSNYQL IWG V1-D1-J1.5 YFCAS SQEARNNQAP LFG
1A4 V4-J20 YYCAL GEGYAQG TFG V4-D1-J2.6 YFCAS SHRDNYEQ YFG
5B7 V1-J8 YLCAT RNMGYK TFG V6-D1-J1.6 FLCAS SRDRGGQ YFG
1C9 V4-J20 YYCAL RGSNAKL TFG V1-D1-J1.1 YFCAS SQRGANTEV FFG
7E10 V1-J17 YLCAA PTSSGSWQL IFG V6-D1-J1.1 FLCAS NIRGQGNTEV FFG
4D10 V4-J18 YYCAL GEDYNQGKL IFG V1-D1-J2.3 YFCAS SRDRGQGAETL YFG
10C1 V13-J8 YFCAA SEDMGYKL TFG V1-D1-J2.3 YFCAS SPRDSAETL YFG
p217 and p290 4B5 V2-J7 YFCAA SALHYSNNRL TLG V6-D2-J2.3 FLCAS TRGTGRAETL YFG
11C11 V13-J37 YFCAA SEAGGADRL TFG V8.3-D2-J2.3 YFCAS TNWGGGAEQ FFG
11H11 V2-J18 YFCAA SGYNQGKL IFG V16-D1-J1.2 TFCAS SPRQTNSDY TFG
11A10 V13-J37 YFCAA SEAGGADRL TFG V1-D2-J2.3 YFCAS SPRDSAETL YFG
V-J and V-D-J gene segments and amino acid sequences of CDR3/ are provided for the monospeciﬁc and promiscuous T-cell clones.
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pathogenicity. Accordingly, adoptive transfer experiments
were carried out in which 10  10
6 cells of the individual
T-cell clones were injected into NOD.scid recipients, and
insulitis and diabetes were examined. Neither monospe-
ciﬁc nor promiscuous T-cell clones induced diabetes 4
weeks after transfer. However, the frequency of intra-
insulitis was signiﬁcantly increased in recipients of pro-
miscuous versus p217- and p290-speciﬁc T-cell clones (Fig.
5). For example, on average, intra-insulitis was detected in
67% (186 of 279) of the islets of mice receiving the
promiscuous T-cell clones (Fig. 5). On the other hand,
intra-insulitis, on average, was detected in only 25% (63 of
252) and 14% (30 of 215) of NOD.scid mice receiving p217-
and p290-speciﬁc T-cell clones, respectively (Fig. 5). These
observations demonstrate that a more aggressive type of
insulitis is mediated by the promiscuous versus monospe-
ciﬁc T-cell clones.
DISCUSSION
Cross-reactivity is an intrinsic property of TCRs that plays
a critical role in T-cell development and homeostasis
(24–26). T-cell cross-reactivity was originally attributed to
molecular mimicry, in which two antigenic peptides share
structural and chemical properties. Molecular mimicry has
been linked to cross-reactive T-cell responses between self
and microbial antigens in a variety of autoimmune dis-
eases, including type 1 diabetes (41–44). However, TCRs
have also been shown to recognize multiple epitopes that
have little or no structural similarities (27–30,45). Further-
more, reports have demonstrated that TCRs speciﬁc for
viral or other foreign antigens recognize nonoverlapping
epitopes from the same antigen (34–36). These promiscu-
ous T-cell clones may represent a subset of CD4
 and
CD8
 T-cells with enhanced effector functions (34–36).
Together, these ﬁndings indicate that a high degree of
inherent plasticity is associated with TCR epitope recog-
nition that in turn may inﬂuence clonotypic selection/
expansion in the periphery. The current study demonstrates
that a relatively high frequency of GAD65-speciﬁc CD4

T-cell clones recognizes two nonoverlapping GAD65 pep-
tides and that this promiscuity correlates with increased
avidity/afﬁnity and an enhanced capacity to mediate insulitis.
Detection of CD4
 T-cells binding both sIA
g7-p217 and sIA
g7-
p290 predominately in the islets of 12-week-old NOD female
mice is noteworthy and is an argument against the possibility
that promiscuous T-cell recognition is an artifact of cloning
and that clones with this speciﬁcity are in fact positively
selected in the thymus.
Studies, including those with NOD mice, have previ-
ously reported that promiscuous T-cell recognition can be
due to expression of dual TCRs (46,47). We show here that
recognition of both p217 and p290 is mediated by a single
TCR based on TCR - and -chain gene cloning (Table 3)
and functional analysis of the promiscuous 11H11 scTCR
(Fig. 4). Despite promiscuous epitope recognition, these
promiscuous TCRs nevertheless display a high degree of
speciﬁcity. For example, other -cell derived autoanti-
gens, such as insulin, GAD67, heat shock protein 60,
carboxypeptidase H, and peripherin, or a large panel of
previously identiﬁed IA
g7-restricted peptides from foreign
antigens fail to stimulate the promiscuous T-cell clones
(R.T., unpublished results). The molecular basis for this
promiscuity is unclear. No preferential usage of V or V
gene segments or CDR3/ motifs was detected among
the panel of promiscuous T-cell clones (Table 3). This
ﬁnding is analogous to other reports demonstrating a high
degree of heterogeneity among TCRs that cross-react with
the same epitopes (48). The two properties shared by the
promiscuous T-cell clones, however, were an increased
[EC50] (Table 2) and relative TCR afﬁnity (Fig. 3) com-
pared with the monospeciﬁc T-cell clones. Importantly,
increased TCR afﬁnity has been correlated with enhanced
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FIG. 4. The promiscuous 11H11 clonotypic TCR binds both sIA
g7-p217
and sIA
g7-p290. BIAcore sensorgrams of 11H11 scTCR binding to
sIA
g7-p217 or sIA
g7-p290 captured by surface-immobilized anti-mouse
IgG2a-speciﬁc antibody at a ﬂow rate of 20 l/min. The corresponding
background responses were subtracted. The latter were obtained by
injecting the analyte over the same anti-mouse IgG2a-speciﬁc antibody
surface in the absence of prior sIA
g7-Ig capture. The highest concen-
trations of each scTCR are indicated, and the other lines are from
twofold dilutions of the highest concentration. KD values are the
average of two independent experiments.
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FIG. 5. Promiscuous T-cell clones exhibit enhanced pathogenicity compared with monospeciﬁc T-cell clones. The frequency of insulitis as
determined by H-E staining was assessed in groups of ﬁve NOD.scid mice receiving monospeciﬁc p217 and p290 and promiscuous T-cell clones
4 weeks after transfer. A minimum of 50 islets was counted for each mouse. P < 10
3, number of islets containing intra-insulitis detected in
promiscuous vs. p217- or p290-monospeciﬁc T-cell clones; 
2. Data are representative of two independent experiments.
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interact with the peptide-MHC complex (28,32,49).
Properties intrinsic to the respective peptides may also
contribute to promiscuous TCR recognition. For instance,
analysis of the core peptides that induce maximum T-cell
proliferation demonstrated that whereas monospeciﬁc and
promiscuous T-cell clones recognized the same p217 core
peptides, this was not the case for p290 (Supplementary
Table 2). All promiscuous T-cell clones recognized an
“extended” p290 core peptide with additional amino acid
residues on the NH2 terminus compared with the minimal
epitopes recognized by monospeciﬁc T-cell clones (Sup-
plementary Table 2). This suggests that the ﬂanking resi-
dues may alter the conformation of bound p290 and/or the
IA
g7 molecule to promote recognition by a promiscuous
TCR. In view of the strong association between MHC and
type 1 diabetes susceptibility, it is tempting to speculate
that properties intrinsic to IA
g7 preferentially promote the
development and/or expansion of promiscuous -cell–
speciﬁc T-cells in NOD mice. In support of this hypothesis,
an increased frequency of T-cell clones recognizing non-
overlapping ovalbumin peptides is detected in NOD versus
a NOD strain congenic for IA
d (NOD.GD) immunized with
ovalbumin (R.T., unpublished data).
Strikingly, promiscuous GAD65-speciﬁc T-cell clones
were established from only 14- and not 4-week-old NOD
female mice (Table 1). This observation suggests that
increased T-cell promiscuity may in fact reﬂect a novel
type of TCR avidity maturation. The Santamaria group (23)
has shown that increased TCR avidity/afﬁnity correlates
with enhanced pathogenicity of IGRP-speciﬁc CD8
 T-
cells. Similarly, we have demonstrated that GAD65-spe-
ciﬁc promiscuous T-cell clones exhibited an increased
[EC50] (Table 2) and relative TCR afﬁnity (Fig. 3), which
also correlated with an increased capacity to mediate
insulitis on adoptive transfer into NOD.scid recipients
(Fig. 5). The four promiscuous T-cell clones individually
mediated signiﬁcantly more intra-insulitis relative to the
monospeciﬁc T-cell clones (Fig. 5). Presumably, promis-
cuous peptide recognition coupled with increased TCR
avidity/afﬁnity enhanced the capacity of the promiscuous
T-cell clones to expand in vivo and efﬁciently penetrate the
islets. The signiﬁcant increase in the frequency of CD4

T-cells that bound both sIA
g7-p217 and -p290 multimers in
the islets and PLNs compared with the MLNs of 12-week-
old NOD female mice is noteworthy (Fig. 1C), further
suggesting antigen-driven expansion of promiscuous T-
cells. A similar tissue distribution was detected for p217
and p290 monospeciﬁc CD4
 T-cells (Supplementary Fig.
1). The lack of induction of diabetes by the T-cell clones
tested is consistent with the notion that p217- and p290-
speciﬁc CD4
 T-cells play a role in supporting the diabe-
togenic response that does not involve, however,
mediating direct -cell destruction. One scenario is that
these clones provide help for -cell–speciﬁc CD8
 (and
CD4
) T-cells by conditioning the extracellular milieu or
“licensing” resident antigen presenting cells in the islets.
Currently, it is unclear whether CD4
 and CD8
 T-cells
speciﬁc for -cell autoantigens other than GAD65 also
exhibit promiscuous epitope recognition and if so, to what
extent. Interestingly, the Goverman group showed in mu-
rine EAE that dual-speciﬁc T-cells recognizing nonoverlap-
ping MBP-speciﬁc peptides could also be detected (33).
Based on this and our own ﬁndings, T-cell promiscuity
may in fact be a common feature of autoreactive T-cells.
Further study is required to determine the relative contri-
bution of T-cell promiscuity in type 1 diabetes and other
T-cell–mediated autoimmune diseases, in addition to de-
ﬁning the molecular basis for dual (multiple) peptide
recognition by TCR.
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